Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline
Sept 27 (Reuters) - Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) on Tuesday said their experimental Alzheimer's drug significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease,…